Paper36072003
ABO blood classification and the risk of lung cancer: A meta-analysis and trial sequential analysis.
Yang H and 4 others. Oncol Lett, 2022. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. ABO blood classification and the risk of lung cancer: A meta-analysis and trial sequential analysis. Papers, record 36072003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36072003
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- ABO blood classification and the risk of lung cancer: A meta-analysis and trial sequential analysis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23534772 | Lack of any association between blood groups and lung cancer, independent of histology. | Asian Pac J Cancer Prev | 2013 | https://conductscience.org/library/papers/23534772 | PubMed |
| 2 | 6245789 | Expression of A and B tissue isoantigens in benign and malignant lesions of the breast. | Cancer | 1980 | https://conductscience.org/library/papers/6245789 | PubMed |
| 3 | 9334809 | Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens. | Int J Cancer | 1997 | https://conductscience.org/library/papers/9334809 | PubMed |
| 4 | 18626751 | Cancer is a preventable disease that requires major lifestyle changes. | Pharm Res | 2008 | https://conductscience.org/library/papers/18626751 | PubMed |
| 5 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 6 | 23803034 | Association of ABO blood group and risk of lung cancer in a multicenter study in Turkey. | Asian Pac J Cancer Prev | 2013 | https://conductscience.org/library/papers/23803034 | PubMed |
| 7 | 27991657 | Molecular typing for blood group antigens within 40 min by direct polymerase chain reaction from plasma or serum. | Br J Haematol | 2017 | https://conductscience.org/library/papers/27991657 | PubMed |
| 8 | 18464913 | A genome-wide association study identifies protein quantitative trait loci (pQTLs). | PLoS Genet | 2008 | https://conductscience.org/library/papers/18464913 | PubMed |
| 9 | 25244548 | ABO blood group and the risk of cancer among middle-aged people in Taiwan. | Asia Pac J Clin Oncol | 2015 | https://conductscience.org/library/papers/25244548 | PubMed |
| 10 | 13740870 | Blood groups and carcinoma of the lung. | Med J Aust | 1961 | https://conductscience.org/library/papers/13740870 | PubMed |
| 11 | 10580143 | Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer. | Biochim Biophys Acta | 1999 | https://conductscience.org/library/papers/10580143 | PubMed |
| 12 | 25600007 | ABO blood types and cancer risk--a cohort study of 339,432 subjects in Taiwan. | Cancer Epidemiol | 2015 | https://conductscience.org/library/papers/25600007 | PubMed |
| 13 | 12499407 | Expression of histo-blood group A antigen increases resistance to apoptosis and facilitates escape from immune control of rat colon carcinoma cells. | Glycobiology | 2002 | https://conductscience.org/library/papers/12499407 | PubMed |
| 15 | 15322521 | Genetic susceptibility to tobacco-related cancer. | Oncogene | 2004 | https://conductscience.org/library/papers/15322521 | PubMed |
| 16 | 28459327 | AJRCCM: 100-Year Anniversary. The Shifting Landscape for Lung Cancer: Past, Present, and Future. | Am J Respir Crit Care Med | 2017 | https://conductscience.org/library/papers/28459327 | PubMed |
| 17 | 17716025 | EGFR tyrosine kinase inhibitors in lung cancer: an evolving story. | Annu Rev Med | 2008 | https://conductscience.org/library/papers/17716025 | PubMed |
| 18 | 19729612 | Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin. | Arterioscler Thromb Vasc Biol | 2009 | https://conductscience.org/library/papers/19729612 | PubMed |
| 19 | 25155765 | Association between the ABO blood group and risk of common cancers. | J Evid Based Med | 2014 | https://conductscience.org/library/papers/25155765 | PubMed |
| 20 | 11297197 | ABH and Lewis histo-blood group antigens in cancer. | APMIS | 2001 | https://conductscience.org/library/papers/11297197 | PubMed |
| 21 | 3516191 | The expression of ABH and Y blood group antigens in benign and malignant breast tissue: the preservation of the H and Y antigens in malignant epithelium. | Br J Cancer | 1986 | https://conductscience.org/library/papers/3516191 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42477536 | Investigation and characteristics of 115 cases with unexpected antibodies for improving transfusion strategies: a retrospective study. | BMC Immunol | 2026 | https://conductscience.org/library/papers/42477536 | PubMed |
| 42388512 | ABO gene polymorphisms: a molecular bridge linking disease susceptibility to therapeutic outcomes. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42388512 | PubMed |
| 41664054 | Unique clinical features and transcriptomic profiling of carcinogenesis in patients with familial lung cancer in Yunnan Province, Wumeng mountains, China. | Respir Res | 2026 | https://conductscience.org/library/papers/41664054 | PubMed |
| 39802216 | Differential expression of ABO in normal and tumor tissues: Implications for cancer biology and prognosis. | J Taibah Univ Med Sci | 2024 | https://conductscience.org/library/papers/39802216 | PubMed |
| 38769523 | ABO and Rhesus blood groups and multiple health outcomes: an umbrella review of systematic reviews with meta-analyses of observational studies. | BMC Med | 2024 | https://conductscience.org/library/papers/38769523 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABL1 | 25 | PubTator's text mining | https://conductscience.org/library/genes/25 | NCBI Gene |
| ABO | 28 | PubTator's text mining | https://conductscience.org/library/genes/28 | NCBI Gene |
| ICAM1 | 3383 | PubTator's text mining | https://conductscience.org/library/genes/3383 | NCBI Gene |
| SELE | 6401 | PubTator's text mining | https://conductscience.org/library/genes/6401 | NCBI Gene |
| SELP | 6403 | PubTator's text mining | https://conductscience.org/library/genes/6403 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
| XPA | 7507 | PubTator's text mining | https://conductscience.org/library/genes/7507 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36072003
GET https://conductscience.org/api/papers/v1/36072003/references?page=2